A new white paper from the USC Leonard D. Schaeffer Center for Health Policy and Economics has found that Medicare coverage for new classes of weight loss drugs would result in $1 trillion saved by Medicare and the American public over the next 10 years — and save countless lives.

Obesity is an urgent health crisis in the United States, but it’s also the most treatable with the help of medication and treatment-related devices. Currently, Medicare and most private insurers do not cover these aids, so only 1% of eligible patients receive treatments. The result: increased health care disparities that favor the wealthy over middle-class and low-income patients.

To read the full story, click here.